Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...

These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs, known ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

"It was so quick," she said. "I still find myself thinking, ‘has that actually happened?’" Tirzepatide is one of a group of ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

A mixed sales report for Novo Nordisk’s GLP-1 megablockbuster drugs failed to quiet concerns Wednesday that investors may ...

Drugs that belong to the class of GLP-1 receptor agonists could cause muscle loss These drugs reduce appetite and are used ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...